Discover 1,776 paid clinical trials in High Point, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,776
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
for
Metastatic Uveal Melanoma, Cutaneous Melanoma,
Location: Durham NC, Cincinnati OH, Philadelphia PA, Nashville TN,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT03947385
Phase 1, Phase 2, Recruiting
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: Female
Age: 18+
Code: NCT05542407
Phase 1, Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens
for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: Durham NC, Atlanta GA, Baltimore MD, Pittsburgh PA,
Sponsor: Servier Bio-Innovation LLC
Sex: All
Age: 18+
Code: NCT06127407
Phase 3, Recruiting
Lerapolturev (PVSRIPO) in GBM
for
Recurrent Supratentorial Glioblastoma
Location: Durham NC
Sponsor: Darell Bigner
Sex: All
Age: 18+
Code: NCT06177964
Phase 2, Recruiting
Key Longitudinal Associations With Risk and Glioblastoma Outcomes
for
Glioblastoma
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06625684
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
for
Relapsed or Refractory Multiple Myeloma
Location: Durham NC, Roanoke VA, Fredericksburg VA, Norfolk VA,